CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 33 enrolled
Drug / intervention
Aqueous sample +3 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01350323
NCT01350323N/ACompleted
CompareCT.gov

Aqueous Humor Levels of Vascular Endothelial Growth Factor Before and After Intravitreal Bevacizumab in Type 3 Versus Type 1 and 2 Neovascularization. A Prospective, Case-control Study.

University of Molise·interventional·Posted May 9, 2011·Updated May 9, 2011

In Brief

A clinical study evaluating Aqueous sample for Age-related Macular Degeneration. Completed, enrolled 33 participants across 1 site.

Detailed Summary

This is a pilot, prospective, interventional, case-control study investigating aqueous levels of vascular endothelial growth factor (VEGF) in eyes with AMD-related neovascularization treated with intravitreal bevacizumab at the Medical Retina Department, University of Molise, Campobasso.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAge-related Macular Degeneration
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 9, 2011
Enrollment StartMay 1, 2009
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 15.1 years ago

Interventions

Aqueous sampleprocedure

Aqueous sample (0.1ml of aqueous)+ intravitreal injection of bevacizumab (1.25mg/0.05ml)

Aqueous sampleprocedure

Aqueous sample (0.1ml)+intravitreal injection of bevacizumab (1.25mg/0.05ml)

Aqueous sampleprocedure

Aqueous sample (0.1ml)+ intravitreal injection of bevacizumab (1.25mg/0.05ml)

Aqueous sampleprocedure

Aqueous sample (0.1ml)